1. Fleming, DM, Cross, KW, Cobb, WA, Chapman, RS Gender difference in the incidence of shingles. Epidemiol Infect. 2004;132(1):1-5. doi:10.1017/S0950268803001523
Google Scholar | Crossref | Medline2. Härmark, L, van Grootheest, AC. Pharmacovigilance: methods, recent developments and future perspectives. Eur J Clin Pharmacol. 2008;64(8):743-52. doi:10.1007/s00228-008-0475-9
Google Scholar | Crossref | Medline | ISI3. Bergvall, T, Norén, GN, Lindquist, M. Vigigrade: a tool to identify well-documented individual case reports and highlight systematic data quality issues. Drug Saf. 2014;37(1):65-77. doi:10.1007/s40264-013-0131-x
Google Scholar | Crossref | Medline4. Ferreira, AdeF, Romão, TT, Macedo, YS, Pupe, C, Nascimento, OJM. COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy. Eur J Neurol. 2020;27(9):1748-50. doi:10.1111/ene.14361
Google Scholar | Crossref | Medline5. Walter, R, Hartmann, K, Fleisch, F, Reinhart, WH, Kuhn, M. Reactivation of herpesvirus infections after vaccinations? Lancet. 1999;353(9155):810. doi:10.1016/S0140-6736(99)00623-6
Google Scholar | Crossref | Medline6. Edwards I, R . Causality assessment in pharmacovigilance: still a challenge. Drug Saf. 2017;40(5):365-72. doi:10.1007/s40264-017-0509-2
Google Scholar | Crossref | Medline7. Bostan, E, Yalici-Armagan, B. Herpes zoster following inactivated COVID-19 vaccine: a coexistence or coincidence? J Cosmet Dermatol Published Online First. 27 February 2021;20(6):1566–1567. doi:10.1111/jocd.14035
Google Scholar | Crossref8. Vastarella, M, Picone, V, Martora, F, Fabbrocini, G. Herpes zoster after ChAdOx1 nCoV-19 vaccine: a case series. J Eur Acad Dermatol Venereol. 2021;35(12)::e845–e846. doi:10.1111/jdv.17576
Google Scholar | Crossref | Medline9. Santovito, LS, Pinna, G. A case of reactivation of varicella-zoster virus after BNT162b2 vaccine second dose? Inflamm Res. 2021;70(9):935-7. doi:10.1007/s00011-021-01491-w
Google Scholar | Crossref | Medline10. Lee, C, Cotter, D, Basa, J, Greenberg, HL. 20 post-COVID-19 vaccine-related shingles cases seen at the Las Vegas dermatology clinic and sent to us via social media. J Cosmet Dermatol. 2021;20(7):1960-4. doi:10.1111/jocd.14210
Google Scholar | Crossref | Medline11. Rizk, JG, Barr, CE, Rizk, Y, Lewin, JC. The next frontier in vaccine safety and VAERS: lessons from COVID-19 and ten recommendations for action. Vaccine. 2021;39(41):6017-8. doi:10.1016/j.vaccine.2021.08.006
Google Scholar | Crossref | Medline12. Perry, C, Mizer, A, Wynn, A, Kruczek, C. Countering COVID-19 vaccine hesitancy. The Southwest Respiratory and Critical Care Chronicles. 2020;8(36):32-46. doi:10.12746/swrccc.v8i36.749
Google Scholar | Crossref13. Baines, A, Ittefaq, M, Abwao, M. #Scamdemic, #plandemic, or #scaredemic: what Parler social media platform tells us about COVID-19 vaccine. Vaccines (Basel). 2021;9(5):421. doi:10.3390/vaccines9050421
Google Scholar | Crossref | Medline14. Chen, G, Li, X, Sun, M, Zhou, Y, Yin, M, Zhao, B, et al. COVID-19 mRNA vaccines Are generally safe in the short term: a vaccine vigilance real-world study says. Front Immunol. 2021;12:669010. doi:10.3389/fimmu.2021.669010
Google Scholar | Crossref | Medline15. Prasad, A . Anti-science misinformation and conspiracies: COVID-19, post-truth, and science & technology studies (STS). Science, Technology and Society. 2021. 097172182110034. doi:10.1177/09717218211003413
Google Scholar | SAGE Journals